Idea principal
This narrative review ranks the Mediterranean diet as the best-supported eating pattern for insulin resistance, with consistent HOMA-IR reductions and a 31% lower type 2 diabetes incidence in PREDIMED-Plus. Most studies rely on surrogate insulin-resistance measures and last 26 weeks or less, so long-term benefits for hard outcomes are unproven.
Study design
Artículo de investigación
Reading basis
Published abstract
Reading focus
Design & applicability
Esta explicación editorial está disponible en inglés, chino simplificado y chino tradicional. Esta interfaz muestra la lectura en inglés.
Pregunta de investigación
Insulin resistance underlies type 2 diabetes, metabolic syndrome, fatty liver disease, PCOS and heart disease, and people want to know which diet helps most. The authors reviewed the mechanisms and compared the evidence for specific dietary patterns.
Población y método
Narrative review. A structured search of PubMed/MEDLINE and Embase (up to January 2026) prioritized randomized controlled trials, systematic reviews, meta-analyses and clinical guidelines. The review covers mechanisms of insulin resistance and the Mediterranean, low-glycaemic-index, DASH, low-carbohydrate, ketogenic and plant-based diets and intermittent fasting. The abstract does not state how many studies were included.
Resultados
The authors’ reported results. Read each estimate with its population and uncertainty.
- 1Insulin resistance is best measured by the hyperinsulinemic-euglycemic clamp (gold standard), while HOMA-IR and QUICKI are validated clinical surrogates.
- 2The Mediterranean diet had the most support, with consistent HOMA-IR reductions, a 31% decrease in type 2 diabetes incidence (PREDIMED-Plus), and benefits in type 2 diabetes, fatty liver disease (MASLD) and PCOS.
- 3Low-GI and DASH diets improve insulin responses after meals, and are particularly effective in PCOS.
- 4Low-carbohydrate and ketogenic diets gave the largest short-term drops in fasting glucose and insulin secretion, though long-term sustainability needs study. Plant-based diets and intermittent fasting improve insulin resistance mainly through weight loss and gut microbiota changes.
Límites e incertidumbre
- 1Most studies used surrogate insulin-resistance indices rather than hard outcomes such as diabetes complications or heart events.
- 2Most trials were short, at 26 weeks or less, so durability of the diets is unclear.
- 3It is a narrative review without pooled estimates, and the abstract does not say how many trials were included or how they were weighed. The 31% figure comes from one trial. This reading is based on the abstract only.
Relevancia práctica
If the goal is better insulin sensitivity, the Mediterranean pattern has the strongest backing, while low-carbohydrate approaches may lower glucose fastest in the short run. The authors say the best choice depends on a person's metabolic profile, other conditions and ability to stick with it. Anyone with diabetes or on medication should adjust diet with their clinician.
Tus datos
Weight, waist, food logs and, if you use one, continuous glucose monitor (CGM) trends can show how your own body responds to a diet change. Compare weeks of similar activity and sleep, use the same device, and do not expect the lab indices HOMA-IR or QUICKI from a wearable.
Cómo interpretar la evidencia
The index does not establish a precise design. Read the methods before making causal claims; check population, comparator, outcomes and uncertainty in the source.
Resumen estructurado de los autores English
El resumen original en inglés se reproduce con atribución bajo la licencia indicada. Es una fuente, no una interpretación de MoveVitals. El análisis preparado figura arriba; verifica los resultados importantes en la fuente.
Background
Insulin resistance (IR) is a hallmark of metabolic disorders including type 2 diabetes mellitus (T2DM), metabolic syndrome, metabolic dysfunction-associated steatotic liver disease (MASLD), obesity, polycystic ovary syndrome (PCOS), and cardiovascular diseases. It arises from impaired insulin signaling in muscle, liver, and adipose tissue, driven by ectopic lipid accumulation, chronic inflammation, oxidative stress, and gut microbiota dysbiosis.
Methods
This narrative review synthesizes IR mechanisms and the evidence on specific dietary patterns. A structured search of PubMed/MEDLINE and Embase (up to January 2026) prioritized RCTs, systematic reviews, meta-analyses, and clinical guidelines.
Results
IR assessment relies on the hyperinsulinemic-euglycemic clamp as gold standard, with HOMA-IR and QUICKI as validated clinical surrogates. The Mediterranean diet is the most evidence-supported strategy, with consistent HOMA-IR reductions, a 31% decrease in T2DM incidence (PREDIMED-Plus), and demonstrated efficacy across T2DM, MASLD, and PCOS. Low-GI and DASH diets improve postprandial insulin dynamics and are particularly effective in PCOS. Low-carbohydrate and ketogenic diets produce the largest short-term reductions in fasting glucose and insulin secretion, though long-term sustainability requires further study. Plant-based diets and intermittent fasting improve IR primarily via weight loss and gut microbiota modulation. Most studies rely on surrogate IR indices and are short-term (≤26 weeks).
Conclusions
Dietary pattern selection should be individualized according to metabolic phenotype, comorbidities, and adherence potential. Larger, longer, head-to-head trials measuring hard clinical outcomes are needed.
Fuentes y atribución
Targeting Insulin Resistance Through Nutrition: Pathophysiological Insights and Dietary Interventions.
Caretto A, Zanardini A, Frontino G, Pedone E.
Nutrients · 2026-03-31
DOI: 10.3390/nu18071119 ↗PubMed · 41978168 ↗Europe PMC · Licencia registrada: cc by ↗Abstract © the original authors, reproduced under the recorded open licence. Translations support reading; use the English record to check terminology and numerical results. Our methodological interpretation is separate from the authors’ conclusions.
Interpretación editorial de MoveVitals · contenido educativo · sin revisión clínica individual registrada
Fuentes verificadas 2026-11-01
Guías prácticas
Leer en contexto
Early time-restricted eating linked to more weight loss and lower insulin than late eating
Pooling 41 randomised trials (2287 participants, median intervention 8 weeks), time-restricted eating was associated with 2.15 kg lower body weight than usual diets (95% CI -2.56 to -1.74), and eating early beat eating late by 1.15 kg (95% CI -1.86 to -0.45). Most trials were short, only 6 study arms tested early eating, and the outcomes were body and blood measures, not heart attacks or deaths.
BMJ Medicine
An 8 a.m. to 4 p.m. eating window added to calorie cutting gave no clear extra weight loss
Among 139 patients with obesity on a calorie-restricted diet, adding an eating window of 8:00 a.m. to 4:00 p.m. led to a mean 12-month weight change of -8.0 kg, versus -6.3 kg with calorie restriction alone. The net difference of -1.8 kg (95% CI -4.0 to 0.4; P = 0.11) was not statistically significant, and the interval cannot rule out either a real benefit or none.
The New England Journal of Medicine
In a 20-person ward trial, an ultra-processed menu led to more eating and weight gain
In 20 adults living in a hospital research unit for 28 days, an ultra-processed menu led them to eat 508 kcal/day more (± 106 SE, P = 0.0001) and gain 0.9 kg, while a menu of unprocessed foods led to a 0.9 kg loss, each over 2 weeks and with eating left to appetite. The study was small, short and fully provisioned, so it cannot show what happens in daily life or which feature of the foods drove the extra eating.
Cell Metabolism
Mediterranean diet with olive oil or nuts linked to fewer heart events (corrected trial)
Among 7447 Spanish adults aged 55 to 80 at high cardiovascular risk, those assigned to a Mediterranean diet with extra-virgin olive oil (HR 0.69, 95% CI 0.53 to 0.91) or with nuts (HR 0.72, 0.54 to 0.95) had fewer major cardiovascular events than those told to cut dietary fat. The trial had randomisation errors, which is why the 2013 report was withdrawn and the estimates recalculated, so treat this as strong but imperfect evidence.
The New England Journal of Medicine

